secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001104659-24-109539
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed exchanges 8M common shares for pre-funded warrants at $0.001 exercise price
--------------------------------------------------------------------------------

- Exchanged 8,000,000 common shares held by Commodore Capital and Deep Track Biotechnology for pre-funded warrants to purchase 8,000,000 common shares at $0.001 each.
- Warrants are exercisable immediately, no expiration, subject to 9.99% beneficial ownership limitation (can be increased to 19.99% with 61 days notice).
- Company and holders amended Registration Rights Agreement to register resale of warrant shares; prospectus supplement filed with SEC.
- Exchange structured as exempt transaction under Section 3(a)(9) of the Securities Act; no commissions paid.
- Holders originally acquired the shares in a March 2024 private placement of 12.5M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465924109539/0001104659-24-109539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465924109539/tm2426318d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-109539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer